Asymmetric organocatalysis: an enabling technology for medicinal chemistry
Bo Han(Shihezi University), Jun‐Long Li(Chengdu University), Cheng Peng(Shandong First Medical University), Gu He(Sichuan University), Xiang‐Hong He(Chengdu University), Yanqing Liu(Chengdu University)
Cited by 402
Related Papers
Regulated cell death (RCD) in cancer: key pathways and targeted therapies
|Signal Transduction and Targeted Therapy|2022|767
Dual Catalysis Sees the Light: Combining Photoredox with Organo‐, Acid, and Transition‐Metal Catalysis
|Chemistry - A European Journal|2014|697
Trienamines in Asymmetric Organocatalysis: Diels−Alder and Tandem Reactions
|Journal of the American Chemical Society|2011|390
Aminocatalytic Asymmetric Diels–Alder Reactions via HOMO Activation
|Accounts of Chemical Research|2012|380